← IRONWOOD PHARMACEUTICALS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $274.0m |
$298.3m
+8.88%
|
$346.6m
+16.21%
|
$428.4m
+23.59%
|
$389.5m
-9.08%
|
$413.8m
+6.22%
|
$410.6m
-0.76%
|
$442.7m
+7.83%
|
$351.4m
-20.63%
|
$296.2m
-15.72%
|
$389.3m
+31.46%
|
|
| Cost of Revenue | $1.9m |
$19.1m
+922.32%
|
$32.8m
+71.50%
|
$23.9m
-27.10%
|
$3.1m
-86.86%
|
$70.4m
+2143.65%
|
$44.3m
-37.09%
|
$1.2b
+2678.38%
|
$114.0m
-90.73%
|
$115.4m
+1.21%
|
$0
-100.00%
|
|
| Gross Profit (Calculated) (derived) | $272.1m |
$279.2m
+2.61%
|
$313.9m
+12.43%
|
$404.5m
+28.88%
|
$386.4m
-4.49%
|
$343.4m
-11.13%
|
$366.3m
+6.68%
|
($787.1m)
-314.86%
|
$237.4m
+130.16%
|
$180.8m
-23.86%
|
— | |
| Research and Development Expense | $139.5m | $148.2m | $166.5m | $115.0m | $88.1m | $70.4m | $44.3m | $116.1m | $111.4m | $95.1m | $88.7m | |
| Selling, General and Administrative Expense | $173.3m | $233.1m | $241.3m | $172.4m | $140.0m | $111.1m | $116.0m | $158.3m | $144.3m | $82.3m | $64.5m | |
| Amortization of Intangible Assets | $981k | $6.2m | $8.1m | — | — | — | — | — | — | — | — | |
| Operating expenses: | ||||||||||||
| Operating Income (Loss) | ($51.9m) |
($77.4m)
-49.19%
|
($238.9m)
-208.71%
|
$120.1m
+150.28%
|
$142.9m
+18.99%
|
$232.3m
+62.49%
|
$250.3m
+7.78%
|
($945.4m)
-477.66%
|
$93.1m
+109.85%
|
$98.5m
+5.78%
|
$236.1m
+139.67%
|
|
| Interest Expense | $39.2m | $36.4m | $37.7m | $36.6m | $29.5m | $31.1m | $7.6m | $21.6m | — | — | $32.7m | |
| Investment Income, Net | $1.2m | $2.1m | $3.0m | $2.9m | $1.5m | $726k | $9.5m | $19.0m | $4.5m | $4.1m | — | |
| Gain (Loss) on Derivative Instruments, Net, Pretax | $8.1m | ($3.3m) | ($8.7m) | $3.0m | ($6.1m) | ($1.2m) | $182k | $19k | — | — | — | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | — | — | $640k | $193k | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $33.0m | $32.7m | $32.7m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | — | — | — | — | — | $226.5m | $167.1m | $161.2m | $207.4m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | — | $108.9m | $200.7m | $252.4m | ($948.1m) | $65.2m | $70.0m | $207.4m | |
| Current Income Tax Expense (Benefit) | — | — | $0 | $0 | $2.7m | $5.5m | $11.6m | $10.9m | ($3.7m) | $5.2m | $77.5m | |
| Income Tax Expense (Benefit) | $0 | $0 | $0 | $0 | $2.7m | ($327.8m) | $77.4m | $83.5m | $64.3m | $46.0m | $77.5m | |
| Net Income (Loss) Attributable to Parent | ($81.7m) |
($116.9m)
-43.12%
|
($282.4m)
-141.47%
|
$21.5m
+107.62%
|
$106.2m
+393.73%
|
$528.4m
+397.71%
|
$175.1m
-66.87%
|
($1.0b)
-672.50%
|
$880k
+100.09%
|
$24.0m
+2629.20%
|
$129.9m
+440.73%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | ($29.3m) | — | — | $129.9m | |
| Earnings Per Share, Basic | — | — | — | $0.14 | $0.67 | $3.26 | $1.13 | ($6.45) | $0.01 | $0.15 | $0.80 | |
| Earnings Per Share, Diluted | — | — | — | $0.14 | $0.66 | $3.21 | $0.96 | ($6.45) | $0.01 | $0.15 | $0.79 | |
| Income (Loss) from Continuing Operations, Per Basic Share | — | — | — | $0 | $1 | $3 | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | — | $0 | $1 | $3 | — | — | — | — | — | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | 159.4m | 162.2m | 154.4m | 155.4m | 159.1m | 161.8m | 163.1m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | 160.7m | 164.4m | 186.3m | 155.4m | 160.1m | 163.0m | 165.8m | |
| Additional Financial Items | ||||||||||||
| Costs and Expenses | $325.8m | $375.7m | $585.5m | $308.3m | $246.6m | $181.5m | $160.3m | $1.4b | $258.3m | $197.6m | — | |
| Goodwill, Impairment Loss | — | $0 | $0 | $0 | $0 | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | $58.9m | $106.2m | $528.4m | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | ($37.4m) | — | — | — | — | — | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.